In VitroEvaluation of Ertapenem (MK-0826), a Long-Acting Carbapenem, Tested Against Selected Resistant Strains-Reference-Cited by-同舟云学术

In VitroEvaluation of Ertapenem (MK-0826), a Long-Acting Carbapenem, Tested Against Selected Resistant Strains

Published:2001-01 Issue:4 Volume:13 Page:363-376
ISSN:1120-009X
Container-title:Journal of Chemotherapy
language:en
Short-container-title:Journal of Chemotherapy

Author:

Jones R.N.

Publisher

Informa UK Limited

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Oncology

Link

http://www.tandfonline.com/doi/pdf/10.1080/10256018808623883

Reference19 articles.

1. Antibiotic resistance: a current perspective

2. In Vivo Activity and Pharmacokinetic Evaluation of a Novel Long-Acting Carbapenem Antibiotic, MK-826 (L-749,345)

3. National Committee for Clinical Laboratory Standards (NCCLS). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 5th ed; approved standard M7-A5. Wayne, PA, 2000.

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Applications of Microbial Fermentation to Food Products, Chemicals and Pharmaceuticals;Advanced Fermentation and Cell Technology;2021-10-15

2. Medicinal Chemistry of β‐Lactam Antibiotics;Burger's Medicinal Chemistry and Drug Discovery;2021-04-26

3. A Thrice-Weekly Ertapenem Regimen Is Practical for Hemodialysis Patients;Antimicrobial Agents and Chemotherapy;2019-12

4. Efficacy of doripenem against Escherichia coli and Klebsiella pneumoniae in experimental meningitis;Journal of Antimicrobial Chemotherapy;2011-12-16

5. Carbapenem therapy for bacteremia due to extended-spectrum β-lactamase–producing Escherichia coli or Klebsiella pneumoniae;Diagnostic Microbiology and Infectious Disease;2011-05